王宪波教授治疗肝硬化腹水经验

高沐浴; 周桂琴; 冯颖; 李斌; 张群; 刘遥

doi:10.3969/j.issn.1671-038X.2025.03.18

王宪波教授治疗肝硬化腹水经验

- 1.
  北京中医药大学东直门医院脾胃病科(北京，100700)
- 2.
  首都医科大学附属北京地坛医院中西医结合中心
基金项目:
首都医学发展基金(No：2024-1-2173)；国家中医药管理局高水平重点学科(No：zyyzdxk-2023005)

详细信息

通讯作者: 周桂琴，E-mail：zhouguiqin1969@163.com

中图分类号: R256.3

收稿日期: 2024-02-17

刊出日期: 2025-03-15

Professor WANG Xianbo's experience in treating cirrhosis ascites

- 1.
  Department of Spleen and Stomach Diseases, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China
- 2.
  Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital Affiliated to Capital Medical University

More Information

Corresponding author: ZHOU Guiqin, E-mail: zhouguiqin1969@163.com

Received Date: 17 February 2024

Publish Date: 15 March 2025

摘要

摘要: 肝硬化腹水是失代偿期肝硬化患者最常见的并发症之一，其迁移难愈，治疗手段有限，病死率高，是临床中颇为棘手的疾病。中医认为肝硬化腹水属于鼓胀范畴，王宪波教授认为鼓胀是与肝脾肺肾相关的津液代谢紊乱的一类疾病，治疗重在实脾，贯穿始终，同时宣肺理气，令肺脾得畅，若病情进一步发展，可根据病机对症加予活血、温阳、补肾等治法。
- 肝硬化腹水 /
- 鼓胀 /
- 实脾 /
- 名医经验
Abstract: Cirrhosis ascites is one of the most common complications in patients with decompensated cirrhosis. In clinical practice, this condition is intractable and difficult to cure, offering limited treatment options and carrying a high mortality rate. Cirrhosis ascites is categorized as tympanites in traditional Chinese medicine. Professor WANG Xianbo believes that tympanites is a kind of disorder of body fluid metabolism related to liver, spleen, lung and kidney. He proposes that the primary therapeutic approach should focus on tonifying the spleen, while also ensuring the ventilation of the lung and regulation of qi to make sure the spleen functions well and the lungs are unobstructed. If the disease gets worsen, it is necessary to add other treatments, such as promoting blood circulation, warming Yang, and tonifying the kidney, according to the pathogenesis and administer treatments.
- cirrhosis ascites /
- tympanites /
- tonifying the spleen /
- experience of famous doctors

HTML全文

参考文献(10)

[1]	Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2021, 70(1): 9-29. doi: 10.1136/gutjnl-2020-321790
[2]	中华医学肝病学分会. 肝硬化腹水诊疗指南(2023年版)[J]. 中华肝脏病杂志, 2023, 31(8): 813-826.
[3]	刘彬彬, 卫建洪, 姜佳呈, 等. 从气血津液理论探讨鼓胀分期诊疗思路[J]. 亚太传统医药, 2023, 19(4): 100-103.
[4]	时克, 侯艺鑫, 王宪波, 等. 解毒凉血健脾方治疗早中期乙型肝炎相关慢加急性肝衰竭的效果观察[J]. 临床肝胆病杂志, 2021, 37(5): 1065-1069.
[5]	姜婷婷, 江宇泳, 叶永安, 等. 健脾化湿解毒方对急性肝损伤小鼠肠屏障功能的影响[J]. 世界中医药, 2021, 16(7): 1090-1094.
[6]	张健. 从脾论治肝硬化腹水临证探究[J]. 世界中西医结合杂志, 2022, 17(3): 609-612.
[7]	王言, 李雪萍. 健脾补肾温阳方治疗老年糖尿病肾病综合征的临床疗效观察[J]. 现代养生, 2024, 24(9): 675-678.
[8]	齐婧姝, 王宇, 刘成海. 活血化瘀法在肝硬化中医药治疗中的实践应用与发展[J]. 上海中医药杂志, 2023, 57(8): 27-32.
[9]	王春玲, 吴思诺, 于晓艳, 等. 基于淫羊藿治疗下丘脑-垂体-肾上腺/性腺/甲状腺轴功能损伤药物有效化学成分及其作用靶点的网络药理学与分子对接技术分析[J]. 吉林大学学报(医学版), 2023, 49(5): 1296-1303.
[10]	Wang TY, Tan WT, Wang XB, et al. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis[J]. JHEP Rep, 2022, 4(10): 100529.